Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation of Wheatgrass and Tulsi Formulation or Its Effect With Allopathic Drugs

NCT05851040 is registered in ClinicalTrials.gov with Swalife Biotech as lead sponsor.

NCT NCT05851040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05851040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation of Wheatgrass and Tulsi Formulation or Its Effect With Allopathic Drugs
Lead sponsor
Swalife Biotech
Phase
Observational
Overall status
Unknown status
Start date
May 10, 2023
Completion date
October 30, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, high, blood sugar; high, smoking, weight, birth